AKNEL Pharm, s.r.o.Active
Key figures
Key figures
2025Dividends
calculatedNo dividends were distributed.
Balance sheet structure
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 32 723 | 1 500 | 0 | 0 | 0 |
| Profit for the reporting year | -3 841 | -305 | -186 | -340 | -340 |
| Retained earnings of previous periods | -87 274 | -91 978 | -92 283 | -92 470 | -92 810 |
| Total assets | 1 985 | 584 | 414 | 414 | 414 |
| Total liabilities | 93 100 | 92 867 | 92 883 | 93 224 | 93 564 |
| Total equity | -91 115 | -92 283 | -92 469 | -92 810 | -93 150 |
| Calculated dividends | 0 | 863 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Similar companies
Summary: AKNEL Pharm, s.r.o.
Overview
AKNEL Pharm, s.r.o. (IČO 44907117) is a limited liability company (s.r.o.). The company was incorporated in 2009 and has existed for 17 years. Registered office according to the register: Varín. Main activity according to the Statistical Office: maloobchod so športovými potrebami (SK NACE 4763).
People
The statutory body has 2 members. According to the register, the company has 2 shareholders. The registered capital is 6 000 €.
Financial results
The company reported no revenue in 2025. 2025 ended with a loss of 340 €. The company made a loss in all 6 reported years.
Points to note
Equity was negative at the end of 2025 (-93 150 €).
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 9. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.